-
PLoS patchogen: the key mechanism of how Salmonella typhi infects
Time of Update: 2020-02-26
February 27, 2020 / biourn / - a recent study found how Salmonella typhi recognizes the host's immune cells and releases toxins that damage the immune system The findings, published in PLoS patterns o
-
Biorxiv: Chinese scientists reveal the potential T cell and B cell epitopes of 2019 ncov
Time of Update: 2020-02-26
February 26, 2020 / BIOON / -- as of February 26, 2020, 2019-ncov has infected more than 77000 people in more than 26 countries, taking more than 2000 lives 2019-nCoV is a novel coronavirus that cause
-
Science: construct the first human thymocyte map, reveal the origin of human immune system, open the door for the development of new cancer immunotherapy
Time of Update: 2020-02-26
February 26, 2020 / Biovalley BIOON / - -- the first cell map of human thymus may lead to new immunotherapies for cancer and autoimmune diseases Now, in a new study, researchers from institutions such
-
Biorxiv: the first in vitro synthesis of a new coronavirus, only a week!
Time of Update: 2020-02-26
February 26, 2020 / BIOON / -- reverse genetics is an indispensable tool, which has completely changed our understanding of viral pathogenesis and vaccine development Large RNA virus genomes, such as
-
Biovalley recommendation: Top 10 heavyweight studies that must be seen in February
Time of Update: 2020-02-25
In a twinkling of an eye, February is coming to an end What are the highlights of this month's research that we should learn more about? According to the type, heat and research field of this month's
-
Can in-depth analysis of the mechanism of oocyte aging really improve the low success rate of IVF technology?
Time of Update: 2020-02-25
February 25, 2020 / BIOON / -- recently, a report was published in the international journal Cell reports In the previous research report, scientists from the University of New South Wales revealed th
-
Scientists discover the inflammatory disease of their own and deeply analyze the cause of the disease
Time of Update: 2020-02-25
February 25, 2020 / BIOON / -- more than 20 years ago, three generations of American families were transferred to the National Institutes of health for treatment due to an unknown disease Their age wa
-
Covid-19 outbreak, we need to start preparing for the next virus outbreak now!!
Time of Update: 2020-02-25
February 25, 2020 / BIOON / -- the outbreak of coronavirus is a formal crisis, we can't waste it There is no denying that the international community is taking this issue very seriously, because the t
-
Research on the heavyweight highlights that Nature magazine had to read in February
Time of Update: 2020-02-25
Time is always in a hurry In an instant, February is coming to an end In the next two months, what are the highlights of nature's research worth learning? The editor sorted out the relevant articles a
-
Life: why cancer immunocheckpoint treatment promotes tuberculosis infection
Time of Update: 2020-02-25
February 26, 2020 / bioun / - recently, researchers at the University of Southampton found that cancer checkpoint inhibitor therapy has the risk of tuberculosis in some patients Cancer immunotherapy i
-
JAMA netw open: can men increase sperm count through a healthy diet?
Time of Update: 2020-02-25
February 25, 2020 / BIOON / -- listen, guys: a new study shows that a healthy diet is good for your brain and heart as well as your sperm In a Danish study of participants with an average age of 19 an
-
Septic shock innovative therapy! The second phase of adrecizumab concept verification was successful, targeting the recovery of adrenomedullin & maintaining vascular integrity!
Time of Update: 2020-02-25
February 25, 2020 news / BIOON / -- advanced AG is a clinical stage biopharmaceutical company in Germany It was founded in 2009 by a management team with decades of in-depth experience in sepsis and d
-
New drug for multiple sclerosis! Novartis ofatumab is under review in the US and Europe, the first B-cell therapy that can be injected subcutaneously once a month at home!
Time of Update: 2020-02-25
February 25, 2020 / BIOON / -- Novartis, a Swiss pharmaceutical giant, recently announced that the US Food and Drug Administration (FDA) and the European Drug Administration (EMA) have respectively ac
-
Breakthrough drug of chronic graft-versus-host disease (cGVHD)! The total remission rate (ORR) of oral Rock2 inhibitor kd025 for 2 months was more than 60%!
Time of Update: 2020-02-24
February 24, 2020 / BIOON / -- the annual ASBMT / CIBMTR transplantation and Cell Therapy Conference (TCT 2020) was held in Orlando, Florida, USA from February 19 to 23, 2020 It was jointly organized
-
Nature: researchers discover new genetic diseases
Time of Update: 2020-02-24
February 24, 2020 / BIOON / -- research started from zebrafish has now pointed out the role of collagen secretion in various clinical symptoms, as well as in a newly discovered genetic syndrome Dr ELA
-
Nature: new immune cells contribute to tumor immunotherapy
Time of Update: 2020-02-24
February 24, 2020 / BIOON / -- immunotherapy shows great hope for cancer treatment But so far, this method is only effective for a small number of cancer patients (about 20%) In order to improve the t
-
Why is it important to name coronavirus correctly?
Time of Update: 2020-02-23
February 23, 2020 / BIOON / -- don't call this new coronavirus outbreak "Wuhan coronavirus", but start to adapt to "covid-19" This is the World Health Organization's recommended name for the disease W
-
Recent progress in breast cancer research!
Time of Update: 2020-02-23
In this paper, I have compiled several research reports to jointly interpret the recent progress of scientists in the field of breast cancer research and share with you! Photo source: cc0 public domai
-
Rituxan, one of Roche's King brand biological agents, was added with new indications to treat acquired thrombocytopenic purpura (attP)!
Time of Update: 2020-02-23
February 23, 2020 / BIOON / -- Chugai, a Japanese pharmaceutical company controlled by Roche, and zenyaku Kogyo) recently announced that Japan's Ministry of health, labor and welfare (MHLW) has approv
-
The first IL-31 receptor blocking antibody! Nemolizumab treatment of pruritus nodosa (PN) stage II clinical significantly reduced the degree of pruritus!
Time of Update: 2020-02-23
February 23, 2020 / Biovalley BIOON / -- Galderma is the world's largest independent global dermatology company and the leader in research and development of scientifically defined and medically prove
